Treatment for Patients with High FAST Score Dementia
For patients with high FAST scores indicating severe dementia, the recommended treatment is memantine (either alone or in combination with donepezil), along with comprehensive non-pharmacological interventions focused on comfort care and quality of life. 1
Pharmacological Management
Severe Dementia (High FAST Score)
First-line medication approach:
- Memantine is recommended as the primary treatment for moderate to severe Alzheimer's disease 1, 2
- Consider combination therapy: memantine plus donepezil for enhanced benefits in severe dementia 1, 2
- Memantine dosing: Start at 5 mg once daily and increase weekly by 5 mg/day in divided doses to a target of 20 mg/day (10 mg twice daily) 2
Evidence for combination therapy:
- Clinical trials show that memantine/donepezil combination therapy provides statistically significant benefits over donepezil alone in severe dementia 2
- At 24 weeks, combination therapy showed a 1.6-point difference in ADCS-ADL scores and a 3.3-point difference in SIB scores compared to donepezil monotherapy 2
Cholinesterase Inhibitors
If the patient is already on a cholinesterase inhibitor:
Important caution: Monitor for cholinergic side effects including gastrointestinal symptoms (7-30% incidence), dizziness, and potential bradycardia in patients with cardiovascular history 1
Non-Pharmacological Interventions
Environment and Daily Care
- Provide predictable routines for meals, exercise, and bedtime 1
- Break complex tasks into simple steps 1
- Implement environmental modifications:
- Install safety locks on doors and gates
- Use color-coded or graphic labels for orientation
- Install grab bars in bathrooms
- Ensure adequate lighting, especially at night
- Reduce excess stimulation and clutter 1
Physical and Cognitive Support
- Implement group or individual physical exercise appropriate for severe dementia to maintain physical function 1
- For patients with high FAST scores, cognitive stimulation should be simple and tailored to their limited abilities 1
End-of-Life Care Considerations
As patients with high FAST scores are often approaching end-of-life care needs:
Shift focus to comfort care and quality of life:
- Address nutrition, hydration, and infection management appropriately 1
- Intensify symptom management for pain, dyspnea, and other distressing symptoms 1
- Consider discontinuing cholinesterase inhibitors if there is no clinically meaningful benefit, development of end-stage dementia, intolerable side effects, or poor medication adherence 1
- Do not discontinue cholinesterase inhibitors if the patient has clinically meaningful psychotic symptoms, agitation, or aggression until these symptoms have stabilized 1
Advance care planning:
Caregiver Support
- Implement psychosocial and psychoeducational interventions for caregivers 1
- Provide training in distraction and redirection techniques for problematic behaviors 1
- Connect caregivers with support groups and respite care options 1
Treatment Algorithm
- Assess severity using FAST score and other cognitive/functional measures
- For high FAST scores (severe dementia):
- Start memantine at 5 mg daily, titrating to 20 mg daily over 4 weeks
- If already on donepezil, continue and add memantine for combination therapy
- If not on any medication, consider starting memantine alone
- Implement comprehensive non-pharmacological interventions
- Reassess regularly for medication effectiveness, side effects, and need for palliative approach
- Provide caregiver support and education
Common Pitfalls to Avoid
- Overmedication: Avoid excessive medication that may worsen quality of life without meaningful benefit
- Undertreating symptoms: Pain and distress may present as behavioral issues in severe dementia
- Neglecting caregiver needs: Caregiver burnout can negatively impact patient care
- Delayed palliative care integration: Patients with high FAST scores often benefit from early palliative care approaches
Remember that while pharmacological interventions may provide modest benefits, the focus for patients with high FAST scores should increasingly shift toward comfort, dignity, and quality of life as the disease progresses.